G, F., C, P., G, A., C, N., G, S., D, B., . . . AM, D. (2001). Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancer. Oncology, 60(3), 214. https://doi.org/10.1159/000055321
Chicago Style (17th ed.) CitationG, Fountzilas, et al. "Dose-dense Sequential Adjuvant Chemotherapy with Epirubicin, Paclitaxel and CMF in High-risk Breast Cancer." Oncology 60, no. 3 (2001): 214. https://doi.org/10.1159/000055321.
MLA (9th ed.) CitationG, Fountzilas, et al. "Dose-dense Sequential Adjuvant Chemotherapy with Epirubicin, Paclitaxel and CMF in High-risk Breast Cancer." Oncology, vol. 60, no. 3, 2001, p. 214, https://doi.org/10.1159/000055321.
Warning: These citations may not always be 100% accurate.